Pregnancy and Parenting Women

Resource Name

Brief Description

ACOG Committee Opinion on Opioid Use and Opioid Use Disorder in Pregnancy

The American College of Obstetricians and Gynecologists (ACOG) came together to articulate a committee opinion on opioid use and opioid use disorder in pregnancy. Within the article, ACOG makes clinical recommendations and conclusions to aid clinicians in providing obstetric and gynecologic care treating patients with OUD.

Webinar on Treating Maternal Opioid Addiction with Buprenorphine

The California HealthCare Foundation funded this webinar that reviews the basics of buprenorphine treatment in pregnancy to help rural clinicians improve outcomes for women and infants exposed to opioids. This hour-long webinar teaches participants about the evidence supporting buprenorphine in pregnancy, the basics of prenatal treatment, intrapartum management, management of neonates, and practical considerations for rural practices.

Webinar Series on Opioid Use Disorders and Treatment

The National Center on Substance Abuse and Child Welfare developed a webinar series on medication-assisted treatment for families affected by substance use disorders, opioid use in pregnancy and treatment for Neonatal Abstinence Syndrome. The webinar features topics such as collaborative approaches to treating pregnant women with OUD, an intervention framework for infants with prenatal exposure and their families and improving understanding of medically-assisted treatment practices (MAT).

Treating Opioid Use Disorder during Pregnancy Brochure

The National Institute on Drug Abuse developed this brochure for providers and patients to guide both parties through choosing to treat OUD in pregnancy. Topics covered include an overview of the risks of opioid misuse in pregnancy, descriptions of neonatal abstinence syndrome, information about MAT and details on how to improve engagement in treatment.

A Collaborative Approach to the Treatment of Pregnancy Women with Opioid Use Disorder

This Substance Abuse and Mental Health Services Administration (SAMHSA) publication supports the efforts of states, tribes and local communities in addressing the needs of pregnant women with opioid use disorders, their infants and families. The report begins by describing the scope of the problem and providing guidelines for supporting collaborative policy and practice and continues onto providing a comprehensive framework for intervention and guide for collaborative planning. The report concludes with a case study from Burlington, Vermont to provide added perspective.

Treating Women Who are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of their Infants and Children: Literature Review to Support National Guidance

This 2017 article was published in the Journal of Addiction Medicine and describes the results of a literature review to identify 75 peer-reviewed articles that found evidence on treating women with OUD who were pregnant or parenting. The article concludes that women with OUD can be treated through medically-assisted treatment (namely methadone or buprenorphine) during pregnancy, and that neonatal abstinence syndrome is an expected and manageable condition arising from maternal OUD.

The ASAM National Practice Guideline Special Populations Webinar (Pregnancy Women)

This free webinar provides an overview of the recommendations and in-depth information on treating pregnant women from American Society of Addiction Medicine’s (ASAM) National Practice Guidelines for the Use of Medications in the Treatment of Opioid Use Disorders. The webinar is oriented toward clinicians whose roles entail evaluating and providing authorization for pharmacological treatments for patients.

Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and their Infants

This new resource, published January 2018 by SAMHSA, provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The Clinical Guide helps healthcare professionals and patients determine the most clinically appropriate action for a situation and informs individualized treatment decisions.

The Perinatal Provider Toolkit

The toolkit developed through a SAMHSA grant, is a centralized online reference to help health care providers quickly access reputable resource information on perinatal substance use for patient treatment and education. The toolkit is for any member of the healthcare team serving pregnant and postpartum women with substance use disorders and includes patient education materials, provider guidelines, webinars, and more.